Recruiting CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000 Conditions Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more Locations Northwestern University — Chicago, Illinois, United States View Trial Details
Active, Not Recruiting Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer NCT04579224 Conditions Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more Locations Kingman Regional Medical Center — Kingman, Arizona, United States Cancer Center at Saint Joseph's — Phoenix, Arizona, United States Mercy Hospital Fort Smith — Fort Smith, Arkansas, United States CHI Saint Vincent Cancer Center Hot Springs — Hot Springs, Arkansas, United States View all 449 locations View more locations Show fewer locations Loading locations... View Trial Details
